Direct-to-Consumer Advertising of Prescription Pharmaceuticals: A Consumer Perspective from New Zealand
New Zealand is one of only two countries in the world that allows direct-to-consumer (DTC) advertising. Such advertising has increased dramatically since the mid-1990s, and a wide range of promotional activities currently takes place. Compliance with the legislation occurs through an industry body t...
Gespeichert in:
| Veröffentlicht in: | Journal of public policy & marketing 2002-10, Vol.21 (2), p.213-223 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 223 |
|---|---|
| container_issue | 2 |
| container_start_page | 213 |
| container_title | Journal of public policy & marketing |
| container_volume | 21 |
| creator | Coney, Sandra |
| description | New Zealand is one of only two countries in the world that allows direct-to-consumer (DTC) advertising. Such advertising has increased dramatically since the mid-1990s, and a wide range of promotional activities currently takes place. Compliance with the legislation occurs through an industry body that hears complaints over alleged breaches. The weakness of the organized consumer sector in the country means there is a paucity of complaints, yet a self-regulating system is reliant on complaints for compliance. The author describes the unsatisfactory experience of taking a complaint and examines the argument that DTC advertising provides consumers with important information. The author measures DTC advertising against criteria for quality health information and finds it wanting. |
| doi_str_mv | 10.1509/jppm.21.2.213.17592 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_journals_211127307</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30000728</jstor_id><sourcerecordid>30000728</sourcerecordid><originalsourceid>FETCH-LOGICAL-c296t-160ee01ff550624a901751bcfb402fa7118f445fc36149d866f9c77c644da2683</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EEqXwBQjJYp_gsR07YVeVp1RBF7BhE7mOXRI1cbCTIv4el6JuZjb33NEchC6BpJCR4qbp-zalkNI4WAoyK-gRmkDGZSIpkcdoQiRnSQGZOEVnITSEEACWT9D6rvZGD8ngkrnrwtgaj2fV1vihDnW3xs7ipTdB-7ofatfh5afyrdJmHGqtNuEWz_CBWxof-lhWbw223rX4xXzjD6M2qqvO0YmNeXPxv6fo_eH-bf6ULF4fn-ezRaJpIYYEBDGGgLVZRgTlqiDxGVhpu-KEWiUBcst5ZjUTwIsqF8IWWkotOK8UFTmbout9b-_d12jCUDZu9F08WVIAoJIRGUNsH9LeheCNLXtft8r_lEDKndByJzQCJY2DlX9CI3W1p5owOH9AWHRJJM3ZL3mtdBQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211127307</pqid></control><display><type>article</type><title>Direct-to-Consumer Advertising of Prescription Pharmaceuticals: A Consumer Perspective from New Zealand</title><source>Access via SAGE</source><source>PAIS Index</source><source>EBSCOhost Business Source Complete</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Coney, Sandra</creator><creatorcontrib>Coney, Sandra</creatorcontrib><description>New Zealand is one of only two countries in the world that allows direct-to-consumer (DTC) advertising. Such advertising has increased dramatically since the mid-1990s, and a wide range of promotional activities currently takes place. Compliance with the legislation occurs through an industry body that hears complaints over alleged breaches. The weakness of the organized consumer sector in the country means there is a paucity of complaints, yet a self-regulating system is reliant on complaints for compliance. The author describes the unsatisfactory experience of taking a complaint and examines the argument that DTC advertising provides consumers with important information. The author measures DTC advertising against criteria for quality health information and finds it wanting.</description><identifier>ISSN: 0743-9156</identifier><identifier>EISSN: 1547-7207</identifier><identifier>DOI: 10.1509/jppm.21.2.213.17592</identifier><language>eng</language><publisher>Chicago: American Marketing Association</publisher><subject>Advertising ; Advertising campaigns ; Bans ; Bill of Rights-US ; Complaints ; Consumer advertising ; Consumer sectors ; Consumers ; Direct-to-Consumer Advertising of Prescription Drugs: Evaluating Regulatory Policy in the United States and New Zealand ; Drug prescriptions ; Economic activity ; Health information ; Industrial marketing ; Industrial regulation ; Marketing ; Pharmaceutical industry ; Pharmaceutical preparations ; Prescription drugs ; Public policy ; Regulation ; Self regulation ; Television advertising</subject><ispartof>Journal of public policy & marketing, 2002-10, Vol.21 (2), p.213-223</ispartof><rights>Copyright 2002 American Marketing Association</rights><rights>Copyright American Marketing Association Fall 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c296t-160ee01ff550624a901751bcfb402fa7118f445fc36149d866f9c77c644da2683</citedby><cites>FETCH-LOGICAL-c296t-160ee01ff550624a901751bcfb402fa7118f445fc36149d866f9c77c644da2683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30000728$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30000728$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27866,27924,27925,58017,58250</link.rule.ids></links><search><creatorcontrib>Coney, Sandra</creatorcontrib><title>Direct-to-Consumer Advertising of Prescription Pharmaceuticals: A Consumer Perspective from New Zealand</title><title>Journal of public policy & marketing</title><description>New Zealand is one of only two countries in the world that allows direct-to-consumer (DTC) advertising. Such advertising has increased dramatically since the mid-1990s, and a wide range of promotional activities currently takes place. Compliance with the legislation occurs through an industry body that hears complaints over alleged breaches. The weakness of the organized consumer sector in the country means there is a paucity of complaints, yet a self-regulating system is reliant on complaints for compliance. The author describes the unsatisfactory experience of taking a complaint and examines the argument that DTC advertising provides consumers with important information. The author measures DTC advertising against criteria for quality health information and finds it wanting.</description><subject>Advertising</subject><subject>Advertising campaigns</subject><subject>Bans</subject><subject>Bill of Rights-US</subject><subject>Complaints</subject><subject>Consumer advertising</subject><subject>Consumer sectors</subject><subject>Consumers</subject><subject>Direct-to-Consumer Advertising of Prescription Drugs: Evaluating Regulatory Policy in the United States and New Zealand</subject><subject>Drug prescriptions</subject><subject>Economic activity</subject><subject>Health information</subject><subject>Industrial marketing</subject><subject>Industrial regulation</subject><subject>Marketing</subject><subject>Pharmaceutical industry</subject><subject>Pharmaceutical preparations</subject><subject>Prescription drugs</subject><subject>Public policy</subject><subject>Regulation</subject><subject>Self regulation</subject><subject>Television advertising</subject><issn>0743-9156</issn><issn>1547-7207</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>7TQ</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNo9kMtOwzAQRS0EEqXwBQjJYp_gsR07YVeVp1RBF7BhE7mOXRI1cbCTIv4el6JuZjb33NEchC6BpJCR4qbp-zalkNI4WAoyK-gRmkDGZSIpkcdoQiRnSQGZOEVnITSEEACWT9D6rvZGD8ngkrnrwtgaj2fV1vihDnW3xs7ipTdB-7ofatfh5afyrdJmHGqtNuEWz_CBWxof-lhWbw223rX4xXzjD6M2qqvO0YmNeXPxv6fo_eH-bf6ULF4fn-ezRaJpIYYEBDGGgLVZRgTlqiDxGVhpu-KEWiUBcst5ZjUTwIsqF8IWWkotOK8UFTmbout9b-_d12jCUDZu9F08WVIAoJIRGUNsH9LeheCNLXtft8r_lEDKndByJzQCJY2DlX9CI3W1p5owOH9AWHRJJM3ZL3mtdBQ</recordid><startdate>20021001</startdate><enddate>20021001</enddate><creator>Coney, Sandra</creator><general>American Marketing Association</general><general>SAGE PUBLICATIONS, INC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>7TQ</scope><scope>7WY</scope><scope>7WZ</scope><scope>7XB</scope><scope>87Z</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DHY</scope><scope>DON</scope><scope>DPSOV</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>F~G</scope><scope>K60</scope><scope>K6~</scope><scope>KC-</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>M2L</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYYUZ</scope><scope>Q9U</scope></search><sort><creationdate>20021001</creationdate><title>Direct-to-Consumer Advertising of Prescription Pharmaceuticals: A Consumer Perspective from New Zealand</title><author>Coney, Sandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c296t-160ee01ff550624a901751bcfb402fa7118f445fc36149d866f9c77c644da2683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Advertising</topic><topic>Advertising campaigns</topic><topic>Bans</topic><topic>Bill of Rights-US</topic><topic>Complaints</topic><topic>Consumer advertising</topic><topic>Consumer sectors</topic><topic>Consumers</topic><topic>Direct-to-Consumer Advertising of Prescription Drugs: Evaluating Regulatory Policy in the United States and New Zealand</topic><topic>Drug prescriptions</topic><topic>Economic activity</topic><topic>Health information</topic><topic>Industrial marketing</topic><topic>Industrial regulation</topic><topic>Marketing</topic><topic>Pharmaceutical industry</topic><topic>Pharmaceutical preparations</topic><topic>Prescription drugs</topic><topic>Public policy</topic><topic>Regulation</topic><topic>Self regulation</topic><topic>Television advertising</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coney, Sandra</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>Global News & ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>PAIS Index</collection><collection>Access via ABI/INFORM (ProQuest)</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>Politics Collection</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Politics Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>Political Science Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ABI/INFORM Collection China</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of public policy & marketing</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coney, Sandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct-to-Consumer Advertising of Prescription Pharmaceuticals: A Consumer Perspective from New Zealand</atitle><jtitle>Journal of public policy & marketing</jtitle><date>2002-10-01</date><risdate>2002</risdate><volume>21</volume><issue>2</issue><spage>213</spage><epage>223</epage><pages>213-223</pages><issn>0743-9156</issn><eissn>1547-7207</eissn><abstract>New Zealand is one of only two countries in the world that allows direct-to-consumer (DTC) advertising. Such advertising has increased dramatically since the mid-1990s, and a wide range of promotional activities currently takes place. Compliance with the legislation occurs through an industry body that hears complaints over alleged breaches. The weakness of the organized consumer sector in the country means there is a paucity of complaints, yet a self-regulating system is reliant on complaints for compliance. The author describes the unsatisfactory experience of taking a complaint and examines the argument that DTC advertising provides consumers with important information. The author measures DTC advertising against criteria for quality health information and finds it wanting.</abstract><cop>Chicago</cop><pub>American Marketing Association</pub><doi>10.1509/jppm.21.2.213.17592</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0743-9156 |
| ispartof | Journal of public policy & marketing, 2002-10, Vol.21 (2), p.213-223 |
| issn | 0743-9156 1547-7207 |
| language | eng |
| recordid | cdi_proquest_journals_211127307 |
| source | Access via SAGE; PAIS Index; EBSCOhost Business Source Complete; JSTOR Archive Collection A-Z Listing |
| subjects | Advertising Advertising campaigns Bans Bill of Rights-US Complaints Consumer advertising Consumer sectors Consumers Direct-to-Consumer Advertising of Prescription Drugs: Evaluating Regulatory Policy in the United States and New Zealand Drug prescriptions Economic activity Health information Industrial marketing Industrial regulation Marketing Pharmaceutical industry Pharmaceutical preparations Prescription drugs Public policy Regulation Self regulation Television advertising |
| title | Direct-to-Consumer Advertising of Prescription Pharmaceuticals: A Consumer Perspective from New Zealand |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T23%3A31%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct-to-Consumer%20Advertising%20of%20Prescription%20Pharmaceuticals:%20A%20Consumer%20Perspective%20from%20New%20Zealand&rft.jtitle=Journal%20of%20public%20policy%20&%20marketing&rft.au=Coney,%20Sandra&rft.date=2002-10-01&rft.volume=21&rft.issue=2&rft.spage=213&rft.epage=223&rft.pages=213-223&rft.issn=0743-9156&rft.eissn=1547-7207&rft_id=info:doi/10.1509/jppm.21.2.213.17592&rft_dat=%3Cjstor_proqu%3E30000728%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211127307&rft_id=info:pmid/&rft_jstor_id=30000728&rfr_iscdi=true |